Day: June 4, 2025

WESTBROOK, Maine, June 04, 2025 (GLOBE NEWSWIRE) — Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a provider of consumer health care and lifestyle products, announced today that it has entered into a $20 million term loan credit agreement, due May 2029 with ACP Agency, LLC. The proceeds will be used to pay down debt and provide the Company with growth capital. Under the terms of the agreement, the Company received a $15 million term loan at closing, with an interest rate of SOFR plus 8.5%. The loan is interest-only through 2025, with quarterly principal payments of $175,000 beginning in January 2026, increasing to $350,000 per quarter in 2027 and beyond. A $2.5 million delayed draw facility and $2.5 million uncommitted term loan incremental facility are also available to the Company. “We are very pleased to have...

Los Angeles, CA and Vancouver, BC, June 04, 2025 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig”), which acquired Streamex Exchange Corporation as its wholly owned subsidiary (“Streamex”) in May 2025, is pleased to announce the appointment of Sean Roosen as Strategic Advisor to Streamex. Mr. Roosen, a globally recognized mining entrepreneur and financier, brings over three decades of experience in building and scaling multibillion-dollar resource ventures. Mr. Roosen is the Founder, Executive Chairman, and Chief Executive Officer of Osisko Development Corp., a premier North American gold development company. He is also the founder and former Executive Chairman and CEO of Osisko Gold Royalties, where he served from its inception in 2014 until 2023. A founding member of Osisko Mining Corporation (2003)...

HCW Biologics earned upfront payment and will recognize revenue of $7.0 million in Q2 2025 MIRAMAR, Fla., June 04, 2025 (GLOBE NEWSWIRE) — HCW Biologics Inc. (“HCWB” or “HCW Biologics”), (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between inflammation and age-related diseases, and WY Biotech Co., Ltd., a China-based company specializing in the early-stage development of recombinant protein drugs and gene/cell therapies, announced today that WY Biotech has completed its due diligence related to HCWB’s technology transfer report, including the characterization of the cell line, delivered on May 13, 2025. In addition, WY Biotech confirmed its commitment to proceed with the development and commercialization...

        4 June 2025        Corporate Announcement No. 48/2025 To NASDAQ Copenhagen A/S Extraordinary General Meeting of Jyske Realkredit A/S On 4 June 2025, Jyske Realkredit A/S held an extraordinary general meeting. Managing Director Niels Erik Jakobsen resigns as Chairman of the Supervisory Board. The general meeting approved the Supervisory Board’s motion to elect Lars Stensgaard Mørch, CEO and Managing Director, as a new member of the Supervisory Board. Subsequently the Supervisory Board consists of Lars Stensgaard Mørch, CEO and Managing Director, Lars Waalen Sandberg, Director, Peter Schleidt, Managing Director, Morten Lykke, Director, Kim Henriksen and Steen Brastrup Clasen, the latter two elected by the employees. At the meeting of the Supervisory Board after the general meeting, the Supervisory Board elected Lars Stensgaard...

– Accomplished Global HR Executive with Deep Franchise and Healthcare Expertise, including CHRO Roles at Kimberly-Clark, Tenet Healthcare, and Yum! Restaurants International, to Join Board –Sandi Karrmann, DirectorSandi Karrmann, DirectorSCOTTSDALE, Ariz., June 04, 2025 (GLOBE NEWSWIRE) — The Joint Corp. (NASDAQ: JYNT), the nation’s largest provider of chiropractic care through The Joint Chiropractic® network, appointed Sandi Karrmann as a Director to help the company strengthen its core, reignite growth and improve profitability. Karrmann increases the board to eight directors. CEO, President and Director Sanjiv Razdan said, “A valuable addition to the board, Sandi brings extensive employee experience with publicly traded healthcare companies and franchises both here in the US and globally. We look...

NEW YORK and STOCKHOLM, June 04, 2025 (GLOBE NEWSWIRE) — Brookfield Asset Management (“Brookfield”) today announced up to SEK 95 billion ($10 billion) of investment to support the development of artificial intelligence (“AI”) infrastructure in Sweden. This investment represents one of Brookfield’s largest AI investments in Europe and extends the partnership with the Swedish government, its public authorities, academia and businesses in the region. The Brookfield investment will be centered on a new large AI center in Strängnäs, Sweden, creating a strategic infrastructure asset to support the country’s national AI strategy. Brookfield will sign a land allocation agreement for c.350,000 sqm of additional land, enabling the data center site to more than double its capacity from 300MW to 750MW. The new site will create over 1,000 new...

TORONTO, June 04, 2025 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company dedicated to developing innovative therapeutics for critical medical needs, is pleased to announce the advancement of its next-generation lyophilized formulation of Bucillamine (“New Bucillamine”). Developed in collaboration with the esteemed University of Waterloo, this breakthrough aims to address significant unmet medical needs and unlock substantial value for shareholders. Strategic Development Targeting High-Value Opportunities Revive is strategically positioning New Bucillamine to target public health emergencies such as pandemic influenza and emerging infectious diseases. Additionally, the company will pursue FDA incentives, including Emergency Use Authorization,...